Iqirvo: The Complete Guide to Its Uses, Benefits, and Side Effects
what is it, Iqirvo? Elafibranor, also known as Iqirvo, is a once-daily oral medication used to treat primary biliary cholangitis (PBC). It is given either in combination with UDCA or as a monotherapy for those unable to tolerate the use of the latter in adults who haven’t responded well to ursodeoxycholic acid (UDCA) alone. Iqirvo